Your browser doesn't support javascript.
loading
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study).
Sicuranza, Anna; Ferrigno, Ilaria; Abruzzese, Elisabetta; Iurlo, Alessandra; Galimberti, Sara; Gozzini, Antonella; Luciano, Luigiana; Stagno, Fabio; Russo Rossi, Antonella; Sgherza, Nicola; Cattaneo, Daniele; Zuanelli Brambilla, Corrado; Marzano, Cristina; Fava, Carmen; Mulas, Olga; Cencini, Emanuele; Santoni, Adele; Sammartano, Vincenzo; Gozzetti, Alessandro; Puccetti, Luca; Bocchia, Monica.
Afiliação
  • Sicuranza A; Hematology Unit, University of Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy.
  • Ferrigno I; Hematology Unit, University of Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy.
  • Abruzzese E; S. Eugenio Hospital, Tor Vergata University, Rome, Italy.
  • Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Galimberti S; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Gozzini A; Department of Cellular Therapies and Transfusion Medicine, AOU Careggi, Florence, Italy.
  • Luciano L; Hematology Unit, AUOP Federico II, Naples, Italy.
  • Stagno F; Hematology Section and BMT Unit, Rodolico Hospital, AOU Policlinico-V. Emanuele, Catania, Italy.
  • Russo Rossi A; Hematology and Transplantation Unit, University of Bari, Bari, Italy.
  • Sgherza N; Hematology and Transplant Center, Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy.
  • Cattaneo D; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Zuanelli Brambilla C; Hematology Unit, University of Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy.
  • Marzano C; Hematology Unit, University of Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy.
  • Fava C; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
  • Mulas O; Department of Medical Sciences and Public Health, University of Cagliari, Businco Hospital, Cagliari, Italy.
  • Cencini E; Hematology Unit, University of Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy.
  • Santoni A; Hematology Unit, University of Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy.
  • Sammartano V; Hematology Unit, University of Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy.
  • Gozzetti A; Hematology Unit, University of Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy.
  • Puccetti L; Hemostasis and Thrombosis Unit, University of Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy.
  • Bocchia M; Hematology Unit, University of Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy.
Front Oncol ; 12: 835563, 2022.
Article em En | MEDLINE | ID: mdl-35178353
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália